Erythrocyte-derived ATP and Perfusion Distribution: Role of Intracellular and Intercellular Communication

Microcirculation

Volumn 19, Issue 5, 2012, Pages 430-439

  Sprague, Randy S ^a   Ellsworth, Mary L ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood flow regulation; Oxygen delivery; Phosphodiesterase; Prostacyclin; Red blood cells

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYCLIC AMP; OXYGEN; PHOSPHODIESTERASE III; PROSTACYCLIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

BLOOD FLOW; CELL COMMUNICATION; CYSTIC FIBROSIS; ERYTHROCYTE; ERYTHROCYTE DEFORMABILITY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INTRACELLULAR SIGNALING; MICROCIRCULATION; MUSCLE PERFUSION; NEGATIVE FEEDBACK; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXYGEN SATURATION; OXYGEN TENSION; OXYGEN TRANSPORT; PERFUSION; POSITIVE FEEDBACK; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SKELETAL MUSCLE; VASCULAR RESISTANCE; VASODILATATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 3; ERYTHROCYTES; HUMANS; OXYGEN; SIGNAL TRANSDUCTION; VASCULAR DISEASES; VASODILATION;

EID: 84863769087     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1111/j.1549-8719.2011.00158.x     Document Type: Review

References (83)

1. Adderley SP, Dufaux EA, Sridharan M, Bowles EA, Hanson MS, Stephenson AH, Ellsworth ML, Sprague RS. Iloprost-and isoproterenol-induced increases in cAMP are regulated by different phosphodiesterases in erythrocytes of both rabbits and humans. Am J Physiol 296: H1617-H1624, 2009.
2. Adderley SP, Sprague RS, Stephenson AH, Hanson MS. Regulation of cAMP by phosphodiesterases in erythrocytes. Pharmacol Rep 62(3): 475-482, 2010.
3. Adderley SP, Sridharan M, Bowles EA, Stephenson AH, Ellsworth ML, Sprague RS. Protein kinases A and C regulate receptor-mediated increases in cAMP in rabbit erythrocytes. Am J Physiol 298: 587-593, 2010.
4. Adderley SP, Sridharan M, Bowles EA, Stephenson AH, Sprague RS, Ellsworth ML. Inhibition of ATP release from erythrocytes: a role for EPACs and PKC. Microcirculation 18(2): 128-135, 2011.
5. Adderley SP, Thuet KM, Sridharan M, Bowles EA, Stephenson AH, Ellsworth ML, Sprague RS. Identification of cytosolic phosphodiesterases in the erythrocyte: a possible role for PDE5. Med Sci Monit 17(5): CR241-CR247, 2011.
6. Arcaro G, Cretti A, Balzano S, Lechi A, Muggeo M, Bonora E, Bonodomma RC. Insulin causes endothelial dysfunction in humans. Circulation 105: 576-582, 2002.
7. Bergfeld GR, Forrester T. Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovasc Res 26: 40-47, 1992.
8. Brand FN, Abbott RD, Kanel WB. Diabetes, intermittent claudication and risk of cardiovascular events. The Framingham Study. Diabetes 38(4): 504-509, 1989.
9. Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium derived hyperpolarizing factors. Circ Res 78: 415-423, 1996.
10. Chalmers C, Bird BD, Whitwam JG. Evaluation of a new thin film tonometer. Br J Anaesth 46: 253-259, 1974.
11. Collins DM, McCullough WT, Ellsworth ML. Conducted vascular responses: communication across the capillary bed. Microvasc Res 56(1): 43-53, 1998.
12. Collison DJ, Rea R, Donnelly R. Masterclass series in peripheral arterial disease. Vasc Med 9: 307-310, 2004.
13. Dazel HH, Westfall DP. Receptors for adenine nucleotides and nucleosides: subclassification, distribution and molecular characterization. Pharmacol Rev 46: 449-466, 1994.
14. Dietrich HH, Ellsworth ML, Sprague RS, Dacey RG Jr. Red blood cell regulation of microvascular tone through adenosine triphosphate. Am J Physiol 278(4): H1294-H1298, 2000.
15. Dietrich HH, Horiuchi T, Xiang C, Falck JR, Hongo K, Dacey RG Jr. Mechanism of ATP-induced local and conducted vasomotor responses in isolated rat cerebral penetrating arterioles. J Vasc Res 46: 253-264, 2008.
16. Dietrich HH, Tyml K. Capillary as a communicating medium in the microvasculature. Microvasc Res 43: 87-99, 1992.
17. Duling BR, Berne RM. Longitudinal gradients in periarteriolar oxygen tension. A possible mechanism for the participation of oxygen in local regulation of blood flow. Circ Res 27: 669-678, 1970.
18. Ellis CG, Goldman D, Hanson MS, Stephenson AH, Milkovich S, Benlamri A, Ellsworth ML, Sprague RS. Defects in oxygen supply to skeletal muscle of prediabetic ZDF rats. Am J Physiol 298: H1661-H1670, 2010.
19. Ellis CG, Milkovich S, Goldman D. Experimental protocol investigating local regulation of oxygen supply in rat skeletal muscle in vivo. J Vasc Res 43(Suppl. 1): 45, 2006.
20. Ellsworth ML. The red blood cell as an oxygen sensor: what is the evidence? Acta Physiol Scand 168: 551-559, 2000.
21. Ellsworth ML, Ellis CG, Goldman D, Stephenson AH, Dietrich HH, Sprague RS. Erythrocytes: oxygen sensors and modulators of vascular tone. Physiology (Bethesda) 24: 107-116, 2009.
22. Ellsworth ML, Ellis CG, Popel AS, Pittman RN. Role of microvessels in oxygen supply to tissue. NIPS 9: 119-123, 1994.
23. Ellsworth ML, Forrester T, Ellis CG, Dietrich HH. The erythrocyte as a regulator of vascular tone. Am J Physiol 269: H2155-H2161, 1995.
24. Ellsworth ML, Pittman RN. Heterogeneity of oxygen diffusion through hamster striated muscles. Am J Physiol 246: H161-H167, 1984.
25. Ellsworth ML, Pittman RN. Arterioles supply oxygen to capillaries by diffusion as well as by convection. Am J Physiol 258: H1240-H1243, 1990.
26. Ellsworth ML, Popel AS, Pittman RN. Assessment and impact of heterogeneities of convective oxygen transport parameters in capillaries of striated muscle: experimental and theoretical. Microvasc Res 35: 241-362, 1988.
27. Forsyth AM, Wan J, Owrutsky PD, Abkarian M, Stone HA. Multiscale approach to link red blood cell dynamics, shear viscosity, and ATP release. Proc Natl Acad Sci U S A 108(27): 10986-10991, 2011.
28. Fowkes FG. Epidemiological research on peripheral vascular disease. J Clin Epidemiol 54: 863-868, 2001.
29. Fukao M, Mason HS, Kenyon JL, Horowitz B, Keef KD. Regulation of BK(Ca) channels expressed in human embryonic kidney 293 cells by epoxyeicosatrienoic acid. Mol Pharmacol 59: 16-23, 2001.
30. Hanson MS, Ellsworth ML, Achilleus D, Stephenson AH, Bowles EA, Sridharan M, Adderley A, Sprague RS. Insulin inhibits low oxygen-induced ATP release from human erythrocytes: implications for vascular control. Microcirculation 16: 424-433, 2009.
31. Hanson MS, Stephenson AH, Bowles EA, Sprague RS. Insulin inhibits human erythrocyte cAMP accumulation and ATP release: role of phosphodiesterase 3 and phosphoinositide 3-kinase. Exp Biol Med 235: 256-262, 2010.
32. Hanson MS, Stephenson AH, Bowles EA, Sridharan M, Adderley S, Sprague RS. Phosphodiesterase 3 is present in rabbit and human erythrocytes and its inhibition potentiates iloprost-induced increases in cAMP. Am J Physiol 295(2): H786-H793, 2008.
33. Hester RL. Uptake of metabolites by postcapillary venules: mechanism for the control of arteriolar diameter. Microvasc Res 46: 254-261, 1993.
34. 2 receptor subtypes producing dilation in rat intracerebral arterioles. Stroke 34: 1473-1478, 2003.
35. Iancu RV, Jones SW, Harvey RD. Compartmentation of cAMP signaling in cardiac myocytes: a computational study. Biophys J 92(9): 3317-3331, 2007. [Erratum in: Biophys J 94(2): 714, 2008]
36. Jaap AJ, Hammersley MS, Shore AC, Tooke JE. Reduced microvascular hyperaemia in subjects at risk of developing type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 37: 214-216, 1994.
37. Jaap AJ, Shore AC, Tooke JE. Relationship of insulin resistance to microvascular dysfunction in subjects with fasting hyperglycemia. Diabetologia 40: 238-243, 1997.
38. Jackson WF. Arteriolar oxygen reactivity: where is the sensor? Am J Physiol 253(22): H1120-H1126, 1987.
39. 2 delivery mediated by hemoglobin oxygenation. Am J Physiol 280: H2833-H2839, 2001.
40. Kanauchi M, Kanauchi K, Inoue T, Kimura K, Saito Y. Surrogate markers of insulin resistance in assessing individuals with new categories "prehypertension" and "prediabetes". Clin Chem Lab Med 45: 35-39, 2007.
41. 2-purinoceptors mediate both vasodilation and vasoconstriction of the isolated rat femoral artery. Eur J Pharmacol 1072: 161-168, 1985.
42. King L. Impaired wound healing in patients with diabetes. Nurs Stand 15(38): 39-45, 2001.
43. Kitamura T, Kitamura Y, Kuroda S, Hino Y, Ando M, Kotani K, Konishi H, Matsuzaki H, Kikkawa U, Ogawa W, Kasuga M. Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt. Mol Cell Biol 19: 6286-6296, 1999.
44. Krogh A. Lecture II (1929): The Distribution and Number of Capillaries in Selected Organs. The Anatomy and Physiology of Capillaries. New York: Hafner Publishing Company, 1959, p. 23.
45. Kurjiaka DT, Segal SS. Conducted vasodilation elevates flow in arteriole networks of hamster striated muscle. Am J Physiol 269: H1723-H1728, 1995.
46. Li C, Xu Q. Mechanical stress-initiated signal transductions in vascular smooth muscle. Cell Signal 12: 435-445, 2000.
47. Liang G, Stephenson AH, Lonigro AJ, Sprague RS. Erythrocytes of humans with cystic fibrosis fail to stimulate nitric oxide synthesis in isolated rabbit lungs. Am J Physiol 288: H1580-H1585, 2005.
48. Locovei S, Bao L, Dahl G. Pannexin 1 in erythrocytes: function without a gap. Proc Natl Acad Sci U S A 103: 7655-7659, 2006.
49. McCullough WT, Collins DM, Ellsworth ML. Arteriolar responses to extracellular ATP in striated muscle. Am J Physiol 272: H1886-H1891, 1997.
50. Melher P, Jeffers B, Estacio R, Schrier R. Association of hypertension and complications in NIDDM. Am J Hypertens 10: 152-161, 1997.
51. Morrish NJ, Wang S-L, Stevens LK, Fuller JH, Keen H, The WHO Multinational Study Group. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetologia 44: S14-S21, 2001.
52. Olearczyk JJ, Stephenson AH, Lonigro AJ, Sprague RS. Heterotrimeric G protein Gi is involved in a signal transduction pathway for ATP release from erythrocytes. Am J Physiol 286: H940-H945, 2004.
53. Olearczyk JJ, Stephenson AH, Lonigro AJ, Sprague RS. NO inhibits signal transduction pathway for ATP release from erythrocytes via its action on heterotrimeric G protein Gi. Am J Physiol 287: H748-H754, 2004.
54. Olschewski H, Olschewski A, Rose F, Schermuly R, Schutte H, Weissmann N, Seeger W, Grimminger F. Physiological basis for the treatment of pulmonary hypertension. J Lab Clin Med 138: 287-297, 2001.
55. Olschewski H, Rose F, Grunig E, Ghofrani HA, Walmrath D, Schulz R, Schermuly R, Grimminger F, Seeger W. Cellular pathophysiology and therapy of pulmonary hypertension. J Lab Clin Med 138: 367-377, 2001.
56. Pittman RN, Duling BR. Oxygen sensitivity of vascular smooth muscle. Microvasc Res 6: 202-211, 1973.
57. Radomski MW, Palmer RM, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 92(1): 181-187, 1987.
58. Saito Y, Eraslan A, Hester RL. Role of EDRFs in the control of arteriolar diameter during increased metabolism of striated muscle. Am J Physiol 267: H195-H200, 1994.
59. 2 transport in skeletal muscle: diffusive exchange between arterioles and capillaries. Am J Physiol 267: H1214-H1221, 1994.
60. Segure JS, Campo C, Ruilope LM, Rodicio JL. Do we need to target 'prediabetic' hypertensive patients? J Hyperten 23: 2119-2125, 2005.
61. 2-induced ATP release from erythrocytes of humans with type 2 diabetes: implications for vascular control. Am J Physiol 301: H2466-H2472, 2011.
62. Sprague RS, Bowles EA, Hanson MS, DuFaux E, Sridharan M, Adderley S, Ellsworth ML, Stephenson AH. Prostacyclin analogues stimulate receptor-mediated cAMP synthesis and ATP release from rabbit and human erythrocytes. Microcirculation 15: 461-471, 2008.
63. Sprague RS, Bowles EA, Olearczyk JJ, Stephenson AH, Lonigro AJ. The role of G protein β subunits in the release of ATP from human erythrocytes. J Physiol Pharmacol 53: 667-674, 2002.
64. Sprague RS, Ellsworth ML, Stephenson AH, Kleinhenz ME, Lonigro AJ. Deformation-induced ATP release from red blood cells requires cystic fibrosis transmembrane conductance regulator activity. Am J Physiol 275: H1726-H1732, 1998.
65. Sprague RS, Ellsworth ML, Stephenson AH, Lonigro AJ. Participation of cAMP in a signal-transduction pathway relating erythrocyte deformation to ATP Release. Am J Physiol 281: C1158-C1164, 2001.
66. Sprague RS, Ellsworth ML, Stephenson AH, Lonigro AJ. Impaired release of ATP from red blood cells of humans with primary pulmonary hypertension. Exp Biol Med 226: 434-439, 2001.
67. 2 supply to skeletal muscle. Am J Physiol 299: H566-H573, 2010.
68. Sprague RS, Stephenson AH, Bowles EA, Stumpf MS, Lonigro AJ. Reduced expression of Gi in erythrocytes of humans with diabetes type 2 is associated with impairment of both cAMP generation and ATP release. Diabetes 55: 3588-3593, 2006.
69. Sprague RS, Stephenson AH, Bowles EA, Stumpf MS, Ricketts G, Lonigro A. Expression of the heterotrimeric G protein Gi and ATP release are impaired in erythrocytes of humans with diabetes mellitus. Adv Exp Med Bio 588: 207-216, 2006.
70. Sprague RS, Stephenson AH, Ellsworth ML. Red not dead: signaling in and from erythrocytes. Trends Endocrinol Metab 18(9): 350-355, 2007.
71. Sridharan M, Adderley SP, Bowles EA, Egan TM, Stephenson AH, Ellsworth ML, Sprague RS. Pannexin 1 is the conduit for low oxygen tension-induced ATP release from human erythrocytes. Am J Physiol 299: H1146-H1152, 2010.
72. Sridharan M, Bowles EA, Richards JP, Krantic M, Davis KL, Dietrich KA, Stephenson AH, Ellsworth ML, Sprague RS. Prostacyclin receptor-mediated ATP release from erythrocytes requires the voltage-dependent anion channel (VDAC). Am J Physiol Heart Circ Physiol 302(3): H553-H559, 2012.
73. Sridharan M, Sprague RS, Adderley SP, Bowles EA, Ellsworth ML, Stephenson AH. Diamide decreases deformability of rabbit erythrocytes and attenuates low oxygen tension-induced ATP release. Exp Biol Med (Maywood) 235(9): 1142-1148, 2010.
74. 2 during nonhypoxic and hypoxic ventilation. Am J Physiol 1993(265): H537-H542, 1993.
75. Stein JC, Ellsworth ML. Capillary oxygen transport during severe hypoxia: role of hemoglobin oxygen affinity. J Appl Physiol 75(4): 1601-1607, 1993.
76. Stern MP. The effect off glycemic control ion the incidence of macrovascular complications of diabetes. Arch Fam Med 7: 155-162, 1998.
77. Uusitipa M, Niskanen L, Siitonen O, Pyorala K. 5-year incidence of atherosclerotic vascular disease in relation to gender, risk factors, insulin level and abnormalities in lipoprotein composition in non-insulin dependent diabetic and non-diabetic individuals. Circulation 82: 27-36, 1990.
78. Wan J, Ristenpart WD, Stone HA. Dynamics of shear-induced ATP release from red blood cells. Proc Natl Acad Sci U S A 105(43): 16432-16437, 2008.
79. Welsh DG, Segal SS. Endothelial and smooth muscle cell conduction in arterioles controlling blood flow. Am J Physiol 274: H178-H186, 1998.
80. Wiernsperger N. Defects in microvascular haemodynamics during prediabetes: contributor or epiphenomenon? Diabetologica 43: 1439-1448, 2000.
81. Wijkander J, Landstrom TR, Manganiello V, Belfrage P, Degerman E. Insulin-induced phosphorylation and activation of phosphodiesterase 3B in rat adipocytes: possible role for protein kinase B but not mitogen-activated protein kinase or p70 S6 kinase. Endocrinology 139: 219-227, 1998.
82. You J, Johnson TD, Childres WF, Bryan RM Jr. Endothelial-mediated dilations of rat middle cerebral arteries by ATP and ADP. Am J Physiol 273: H1472-H1477, 1997.
83. 2 purinoceptors in the cerebrovascular tree of the rat. Am J Physiol 277: H893-H900, 1999.